They indicated that most responsive breast tumors had the highest expression of Keratin 5/7 (KRT5/KRT17) and the lowest expression of endogen receptor (ER), progesterone receptor (PR) or human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene KRT5 and breast neoplasm.